- Home
- MDIA vs ITRM Comparison
MDIA vs ITRM Comparison
Compare MDIA & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDIA | ITRM |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.3M | 24.3M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | MDIA | ITRM |
|---|---|---|
| Price | $0.69 | $0.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 26.1K | ★ 1.0M |
| Earning Date | 11-19-2025 | 02-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $127,477,000.00 | $390,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $325.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 83.96 | N/A |
| 52 Week Low | $0.66 | $0.36 |
| 52 Week High | $1.60 | $2.10 |
Technical Indicators
Market Signals| Indicator | MDIA | ITRM |
|---|---|---|
| Relative Strength Index (RSI) | 27.11 | 34.97 |
| Support Level | $0.66 | $0.44 |
| Resistance Level | $0.81 | $0.49 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 10.93 | 4.96 |
Price Performance
Historical ComparisonAbout MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About ITRM Iterum Therapeutics plc
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.